Kite Pharma Ready To Jump Logistical Hurdles Of CAR-T
Executive Summary
In an interview at the J.P. Morgan conference, Kite Pharma execs explain how the company is gearing up for the challenge of supplying CAR-T therapy for multicenter trials and commercializing a product in 2017.